TWO SIGMA INVESTMENTS, LP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 27 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$78,518
-28.8%
47,300
-14.2%
0.00%
Q2 2023$110,250
-73.0%
55,125
-71.6%
0.00%
-100.0%
Q1 2023$407,597
+2838.1%
194,094
+1816.8%
0.00%
Q4 2022$13,873
+26.1%
10,126
-2.2%
0.00%
Q3 2022$11,000
-60.7%
10,351
-59.4%
0.00%
Q2 2022$28,00025,5100.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders